Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.

Cite

CITATION STYLE

APA

Wang, L., Pan, J., Meng, H., Yang, Z., Zeng, L., & Liu, J. (2022). Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy. Brain Sciences, 12(11). https://doi.org/10.3390/brainsci12111587

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free